Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 360 participants.
Also called NCT00993109
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 360 participants
- Sponsor
- Registry
-
NCT00993109
-
- Other papers using this trial's data
- Improved blood pressure control with nifedipine GITS/valsartan combination versus high-dose valsartan monotherapy in mild-to-moderate hypertensive patients from Asia: results from the ADVISE study, a randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China, South Korea
- Registry status
- Completed
Technical summary
Registry record NCT00993109. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Adalat (Nifedipine, BAYA1040)
- Intervention (Drug)
- Diovan (Valsartan)
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct00993109- Content hash
83301d16a3d1d1fbf69cc99a4202c54381792cefeff76a0a6d0c8891a0aded2e